364 results
8-K
EX-99.1
IDXG
Interpace Biosciences, Inc.
12 Mar 24
Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
7:42pm
expenses
Operating income (loss)
Interest accretion expense
Note payable interest
Other expense, net
Income (loss) from continuing operations before tax …
Provision for income taxes
Income (loss) from continuing operations
Income (loss) from discontinued operations, net of tax
Net income (loss)
Basic
8-K
EX-99.1
IDXG
Interpace Biosciences, Inc.
8 Nov 23
Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
5:14pm
interest
Other expense, net
(Loss) income from continuing operations before tax
Provision (benefit) for income taxes
(Loss) income from continuing operations …
Loss from discontinued operations, net of tax
Net loss
Basic (loss) income per share of common stock:
From continuing operations
From discontinued
8-K
EX-99.1
cdxb1912vnj57
9 Aug 23
Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
3:47pm
8-K
EX-10.1
jhs0k03q5k5xasva0
1 Aug 23
Departure of Directors or Certain Officers
8:59pm
8-K
EX-99.1
h2k7m
12 May 23
Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results
4:34pm
8-K
EX-99.1
yex17mfy xh1ef62
14 Nov 22
Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results
4:52pm
8-K
EX-10.1
hsp0e
4 Oct 22
Departure of Directors or Certain Officers
4:18pm
8-K
EX-99.2
k9mab2zxzet9n7mcox
7 Sep 22
Entry into a Material Definitive Agreement
4:46pm